PlainRecalls
FDA Drug Moderate Class II Terminated

allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 79481-0847-0), b)30-count cartons (NDC 79481-0847-1), and c) 45-count cartons (NDC 79481-0847-2), Distributed by: MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544.

Reported: July 19, 2023 Initiated: February 9, 2023 #D-0906-2023

Product Description

allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 79481-0847-0), b)30-count cartons (NDC 79481-0847-1), and c) 45-count cartons (NDC 79481-0847-2), Distributed by: MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544.

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
L. Perrigo Company
Units Affected
59,688 cartons
Distribution
Nationwide within the USA
Location
Allegan, MI

Frequently Asked Questions

What product was recalled?
allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 79481-0847-0), b)30-count cartons (NDC 79481-0847-1), and c) 45-count cartons (NDC 79481-0847-2), Distributed by: MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544.. Recalled by L. Perrigo Company. Units affected: 59,688 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2023. Severity: Moderate. Recall number: D-0906-2023.